Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	26.3	27.04	44.87	187.8	72.03
Short-Term Investments	26.77	78.79	84.13	-	-
Cash & Short-Term Investments	53.08	105.83	129	187.8	72.03
Cash Growth	-49.85%	-17.96%	-31.31%	160.71%	-6.13%
Other Receivables	-	-	-	-	0.14
Receivables	-	-	-	-	0.14
Prepaid Expenses	2.87	3.76	2.38	2.68	2.67
Other Current Assets	-	0	-	-	-
Total Current Assets	55.94	109.6	131.38	190.48	74.84
Property, Plant & Equipment	13.23	14.66	16.07	0.24	0.14
Long-Term Investments	20.97	17.63	5.62	1.63	-
Other Intangible Assets	0.09	0.2	0.22	0.26	0.32
Other Long-Term Assets	1.93	1.94	1.97	1.93	0.63
Total Assets	92.17	144.03	155.27	194.54	75.93
Accounts Payable	3.19	3.7	1.95	7.13	5.45
Accrued Expenses	5.99	6.52	4.5	7.67	12.03
Current Portion of Leases	1.34	1.25	0.53	-	-
Current Unearned Revenue	-	-	-	-	2.21
Other Current Liabilities	0	-	-	-	2.37
Total Current Liabilities	10.52	11.47	6.99	14.8	22.06
Long-Term Leases	13.42	14.76	16	-	-
Long-Term Unearned Revenue	-	-	-	-	10.17
Other Long-Term Liabilities	-	30	-	-	0.06
Total Liabilities	23.94	56.23	22.99	14.8	32.29
Common Stock	0.07	0.07	0.07	0.07	0.07
Additional Paid-In Capital	372.49	365.59	357.77	351.03	337.76
Retained Earnings	-304.3	-277.87	-225.53	-171.36	-294.19
Comprehensive Income & Other	-0.04	-	-0.04	-	-
Total Common Equity	68.23	87.8	132.27	179.75	43.63
Shareholders' Equity	68.23	87.8	132.27	179.75	43.63
Total Liabilities & Equity	92.17	144.03	155.27	194.54	75.93
Total Debt	14.76	16	16.54	-	-
Net Cash (Debt)	38.32	89.83	112.47	187.8	72.03
Net Cash Growth	-57.34%	-20.13%	-40.11%	160.71%	-6.13%
Net Cash Per Share	0.54	1.27	1.60	2.76	1.23
Filing Date Shares Outstanding	71.08	70.71	70.49	70.37	65.75
Total Common Shares Outstanding	71.01	70.69	70.47	70.36	65.74
Working Capital	45.42	98.13	124.39	175.68	52.78
Book Value Per Share	0.96	1.24	1.88	2.55	0.66
Tangible Book Value	68.13	87.6	132.05	179.49	43.31
Tangible Book Value Per Share	0.96	1.24	1.87	2.55	0.66
Machinery	1.53	1.46	1.42	0.5	0.32
Leasehold Improvements	0.31	0.31	0.31	-	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q